As of the end of November, Livzon Pharma (01513) has repurchased a total of 16.1933 million A shares.

16:38 01/12/2025

Li Zhu Pharmaceuticals (01513) announced that as of November 30, 2025, the company repurchased a total of 16.1933 million A-shares through centralized bidding trading, accounting for 1.79% of the company's total share capital. The highest purchase price was RMB 41.99 per share, the lowest was RMB 33.21 per share, and the total amount spent was RMB 600 million (excluding transaction fees). The repurchase mentioned above is in accordance with the company's established share repurchase plan.

LIVZON PHARMA (01513) announced that as of November 30, 2025, the company repurchased a total of 16.1933 million A shares through centralized bidding trading, accounting for 1.79% of the company's total share capital. The highest purchase price was RMB 41.99 per share, and the lowest price was RMB 33.21 per share. The total amount of funds used was RMB 600 million (excluding transaction fees). The repurchase mentioned above is in line with the company's established share repurchase scheme.

Ningbo Sanxing Medical Electric (601567.SH) subsidiary signs a 160 million yuan overseas contract.

In November, NIO delivered approximately 36,300 cars, a year-on-year increase of 76.3%.

TENFU (06868) spent 2720 Hong Kong dollars to repurchase 1000 shares on December 1st.

Ningbo Sanxing Medical Electric (601567.SH) subsidiary signs a 160 million yuan overseas contract.

In November, NIO delivered approximately 36,300 cars, a year-on-year increase of 76.3%.

TENFU (06868) spent 2720 Hong Kong dollars to repurchase 1000 shares on December 1st.